Bristol Myers Squibb Co. Non-TR
13F holders, Q4 2025 (December 31)3holders −1
1new positions
1sold out
$8.55avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding Bristol Myers Squibb Co. Non-TR in their 13F filings, down 1 from Q3 2025. 1 opened new positions and 1 sold out. The largest holders were KBC Group NV ($11K), Sterling Capital Management LLC ($0) and GAMMA Investing LLC ($0).
- Company
- Bristol Myers Squibb Co. Non-TR
- CUSIP
- 604CVR027
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11K |
| Exits | 1 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 955 shares bought and 2 shares sold, net +953 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| KBC Group NV | 0.00% | New | 955 | $11K |
| Sterling Capital Management LLC | 0.00% | No change | 109 | $0 |
| GAMMA Investing LLC | 0.00% | No change | 223 | $0 |
"% of holder's portfolio" is BRISTOL MYERS SQUIBB CO NON-TR's weight in each manager's 13F, not the share of Bristol Myers Squibb Co. Non-TR the manager owns.